Innovita research offers these cell-based products for researchers:

  • The antitumor leukocyte preparation contains the leukocytes primed to inhibit tumor development and may be effective against different cancers.
  • The antibacterial leukocyte preparation composed of the leukocytes with high antibacterial activity.
  • The antiviral leukocyte preparation composed of the leukocytes with high antiviral activity.
  • The tissue-protective leukocyte preparation consists of the leukocytes primed to contribute to tissue reparative processes and is suitable for the treatment of joint and skin disorders.
  • The thrombocyte (PRP) preparation consists of the thrombocytes and is suitable for the treatment of joint and skin disorders.
  • The serum (orthokine) preparation contains anti-inflammatory and growth factors secreted by cells in the process of blood coagulation. It is intended for the treatment of joint and skin diseases.
  • The T-cell preparation includes the vaccinal T-cells are capable of inducing anti-idiotypic immune responses directed against autoimmune or allergic T-lymphocytes.
  • The cell-based, antitumor vaccine contains immune cells that are effective in initiating tumor-specific immune responses. The cellular preparation is prepared using the following xenogeneic vaccines.
  • Xenovac contains melanoma- and carcinoma-associated differentiation antigens and is useful suitable for the treatment of melanoma and different carcinomas.
  • Testisvac contains testis/cancer differentiation antigens and is suitable for treating different cancers expressing those antigens.
  • Lungvac composes of lung tissue-associated, oncofetal antigens and is useful for the treatment of lung carcinoma and other adenocarcinomas.
  • Colorectalvac includes intestine tissue-associated, oncofetal antigens and could be applicative for colorectal cancer.
  • Brainvac includes brain tissue-associated, oncofetal antigens and could be useful for the treatment of brain cancer.
  • Renalvac includes renal tissue-associated, oncofetal antigens and could be used in the treatment of renal cancer.
  • Breastvac contains breast tissue-associated antigens and could be suitable for the treatment of breast cancer.
  • Pancreasvac contains pancreas tissue-associated antigens and could be useful for the treatment of pancreas cancer.
  • Thyroidvac contains thyroid tissue-associated antigens and is intended for the treatment of thyroid cancer.
  • Ovaryvac contains ovary tissue-associated antigens and is intended for the treatment ovary cancer.